Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hatmi

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Prostaglandins|May 1, 1992
Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophagesM Hatmi, N Havet, B B Vargaftig, et al.
British Journal of Haematology|February 1, 1993
Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathwayM Hatmi, J Randon, A Faili, et al.
British Journal of Haematology|November 14, 1997
Signal transduction involved in the platelet adenylate cyclase sensitization associated with PGH2/TxA2 receptor desensitizationI Elalamy, S Emadi, B B Vargaftig, et al.
Biochimica Et Biophysica Acta|May 20, 1996
Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2S Emadi, I Elalamy, B B Vargaftig, et al.
Journal of Thrombosis and Haemostasis : JTH|December 18, 2009
Heparin-induced multiple electrode aggregometry: a potential tool for improvement of heparin-induced thrombocytopenia diagnosisI Elalamy, V Galea, M Hatmi, et al.
Biochemical Pharmacology|May 5, 1993
Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alphaA Faili, J Randon, B B Vargaftig, et al.
British Journal of Pharmacology|August 1, 1985
Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptorL G Carmo, M Hatmi, D Rotilio, et al.
Blood|October 26, 2000
Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregationI Kazes, I Elalamy, J D Sraer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activationC Mounier, M Hatmi, A Faili, et al.
European Journal of Biochemistry|August 15, 1993
Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activationC Mounier, A Faili, B B Vargaftig, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Prostaglandins|May 1, 1992
Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophagesM Hatmi, N Havet, B B Vargaftig, et al.
British Journal of Haematology|February 1, 1993
Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathwayM Hatmi, J Randon, A Faili, et al.
British Journal of Haematology|November 14, 1997
Signal transduction involved in the platelet adenylate cyclase sensitization associated with PGH2/TxA2 receptor desensitizationI Elalamy, S Emadi, B B Vargaftig, et al.
Biochimica Et Biophysica Acta|May 20, 1996
Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2S Emadi, I Elalamy, B B Vargaftig, et al.
Journal of Thrombosis and Haemostasis : JTH|December 18, 2009
Heparin-induced multiple electrode aggregometry: a potential tool for improvement of heparin-induced thrombocytopenia diagnosisI Elalamy, V Galea, M Hatmi, et al.
Biochemical Pharmacology|May 5, 1993
Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alphaA Faili, J Randon, B B Vargaftig, et al.
British Journal of Pharmacology|August 1, 1985
Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptorL G Carmo, M Hatmi, D Rotilio, et al.
Blood|October 26, 2000
Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregationI Kazes, I Elalamy, J D Sraer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activationC Mounier, M Hatmi, A Faili, et al.
European Journal of Biochemistry|August 15, 1993
Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activationC Mounier, A Faili, B B Vargaftig, et al.
Pageof 4